Spray-dried biologics market to reach $3.2 billion by 2030 at 11.4% CAGR, driven by increasing demand for biopharmaceuticals and need for improved stability and shelf-life formulations.
Read More
Sports medicine market to reach $12.77 billion by 2030 at 7.5% CAGR, driven by rise in sports injuries and growing use of medical devices for injury treatment and performance recovery.
Read More
Spine biologics market to reach $3.17 billion by 2030 at 5.0% CAGR, driven by rising number of road accidents and increasing demand for advanced spinal fusion and bone healing solutions.
Read More
Spinal muscular atrophy treatment market to reach $10.38 billion by 2030 at 15.2% CAGR, driven by growing focus on gene therapy and advancement of one-time targeted genetic treatments.
Read More
Sphingosine 1 phosphate receptor modulator drugs market to reach $3.37 billion by 2030 at 5.5% CAGR, driven by rising prevalence of autoimmune diseases requiring targeted immune modulation.
Read More
Specific antiviral drugs for covid 19 market to reach $33.17 billion by 2030 at 16.8% CAGR, driven by rising number of covid-19 cases and emergence of new variants increasing treatment demand.
Read More
Specialty supplements market to reach $69.18 billion by 2030 at 8.2% CAGR, driven by increasing health consciousness and rising consumer demand for targeted nutritional products.
Read More
Specialty pharmaceuticals market to reach $943.31 billion by 2030 at 9.6% CAGR, driven by increasing prevalence of chronic diseases and growing need for targeted high-efficacy therapies.
Read More
Specialty generics market to reach $214.22 billion by 2030 at 14.9% CAGR, driven by surge in chronic diseases and increasing demand for cost-effective treatments for complex conditions.
Read More
Specialty enzymes market to reach $10.07 billion by 2030 at 6.6% CAGR, driven by growing investment in biotechnology research and development and rising demand for high-efficiency enzymes.
Read More